Globe Life (NYSE:GL) Issues FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 15.400-15.90 for the period, compared to the consensus earnings per share estimate of 15.320. The company issued revenue guidance of -.

Globe Life Stock Up 1.7%

Shares of GL opened at $153.77 on Friday. Globe Life has a one year low of $111.13 and a one year high of $154.04. The company has a market cap of $12.06 billion, a P/E ratio of 10.63 and a beta of 0.47. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a 50 day simple moving average of $143.51 and a two-hundred day simple moving average of $139.39.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts forecast that Globe Life will post 15.32 EPS for the current fiscal year.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. This is an increase from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio is currently 9.13%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on GL. Truist Financial lifted their target price on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a report on Thursday, March 26th. Evercore set a $157.00 price target on shares of Globe Life in a research note on Wednesday, February 18th. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, Wells Fargo & Company upped their price objective on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life currently has an average rating of “Buy” and an average target price of $172.11.

Insider Buying and Selling at Globe Life

In other news, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the sale, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This trade represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director owned 3,372 shares in the company, valued at approximately $498,752.52. This trade represents a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 82,807 shares of company stock worth $12,041,286 over the last three months. 2.11% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Globe Life

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nomura Holdings Inc. bought a new stake in shares of Globe Life in the third quarter worth $278,000. BTG Pactual Asset Management US LLC bought a new position in Globe Life during the 4th quarter worth $270,000. Parallel Advisors LLC raised its position in Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after purchasing an additional 87 shares during the last quarter. NorthRock Partners LLC acquired a new position in Globe Life during the 3rd quarter worth about $208,000. Finally, Harvest Fund Management Co. Ltd lifted its holdings in Globe Life by 755.0% during the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,026 shares of the company’s stock worth $147,000 after buying an additional 906 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.